CT News and Research RSS Feed - CT News and Research

Screening smokers with community-acquired pneumonia could facilitate early diagnosis of lung cancer

Screening smokers with community-acquired pneumonia could facilitate early diagnosis of lung cancer

Lung cancer is the leading cause of cancer mortality in the United States, with a five-year survival rate of just 17 percent. Smoking causes approximately 85 percent of all lung cancer cases, only 15 percent of which are diagnosed at an early stage. Most efforts to obtain early diagnosis have been unsuccessful, largely due to the highly aggressive nature of the disease. [More]
New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

Royal Philips and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care. [More]
New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

New injectable agent can potentially increase surgeon's ability to remove cancerous tumor during surgery

Doctors at the Duke University School of Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon's ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology and Lumicell Inc. [More]
NIH-funded clinical study examines new method for sparing healthy lung tissue during radiotherapy

NIH-funded clinical study examines new method for sparing healthy lung tissue during radiotherapy

A newly NIH funded clinical trial (NCT02528942) by University of Colorado Cancer Center investigators and collaborators at Beaumont Health in Michigan and the University of Texas Medical Branch is evaluating a new method for pinpointing and sparing healthy lung tissue during lung cancer radiotherapy. [More]
Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Researchers from Memphis, Tennessee, have examined intracranial gunshot wounds (GSWs) in children and adolescents, and identified nine clinical, laboratory, and radiological factors that were predictive of these patients' outcomes. [More]
Novel imaging-based method as accurate as current standard-of-care for breast cancer treatment

Novel imaging-based method as accurate as current standard-of-care for breast cancer treatment

A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The results suggest that the method might lead to more optimal treatment of individual patients. [More]
DATATRAK announces date for 2015 Annual Meeting of Shareholders

DATATRAK announces date for 2015 Annual Meeting of Shareholders

DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601. [More]
Concussion expert shares important information on sports-related concussions

Concussion expert shares important information on sports-related concussions

The Sports Concussion Program in the Children's Orthopaedic Center at Children's Hospital Los Angeles is the only pediatric program of its kind in Southern California. [More]
Personalized respiratory-motion system enables more precise lung cancer imaging

Personalized respiratory-motion system enables more precise lung cancer imaging

Lung cancer patients know that precise medical imaging can help a surgeon eradicate tumors and preserve healthy tissue. [More]
CTA scans with reduced amount of contrast medium and radiation dose still provide good image quality

CTA scans with reduced amount of contrast medium and radiation dose still provide good image quality

Wouter Nijhof obtained his PhD at the University of Twente for the research he conducted in collaboration with the Radiology department at the Jeroen Bosch Hospital in 's-Hertogenbosch. [More]
Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

A national study involving 53,000 patients and 11 institutions (including Wake Forest Baptist) compared CT screens with chest X-rays and found that the scanning reduced lung cancer mortality by 20 percent in this high-risk population. [More]
HealthSouth Round Rock informs individuals of possible theft of health information

HealthSouth Round Rock informs individuals of possible theft of health information

HealthSouth Rehabilitation Hospital of Round Rock, previously Reliant Rehabilitation Hospital Central Texas, is currently notifying potentially affected individuals that a laptop containing unsecured protected health information was stolen from the trunk of an employee's vehicle on or around Oct. 21, 2015. [More]
Study shows more patients with advanced NSCLC may benefit from pembrolizumab

Study shows more patients with advanced NSCLC may benefit from pembrolizumab

More patients with advanced non-small-cell lung cancer (NSCLC) could benefit from pembrolizumab, says Professor Roy Herbst, Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, presenting promising results from the pivotal phase 2/3 KEYNOTE-010 trial at the first ESMO Asia Congress in Singapore), in conjunction with a publication in The Lancet. [More]
Roche announces availability of cobas HBVassay for use on cobas 4800 System

Roche announces availability of cobas HBVassay for use on cobas 4800 System

Roche announced today the commercial availability of the cobas HBVassay for use on the cobas 4800 System in countries accepting the CE mark. This new molecular diagnostic assay expands the available virology menu on the cobas 4800 System, improving system efficiency and providing testing flexibility that allows physicians to assess a patient's response to antiviral therapy. [More]
Combination therapy can help overcome endocrine resistance in women with advanced breast cancer

Combination therapy can help overcome endocrine resistance in women with advanced breast cancer

Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer. [More]
Asian-American caregivers experience greater demand for family caregiving

Asian-American caregivers experience greater demand for family caregiving

Asian-Americans not only have a desire to care for aging relatives themselves, but it is part of their common cultural practices and norms. As a result, Asian-American caregivers experience a greater demand for family caregiving than other cultural and ethnic groups. [More]
Novel strategies on the way for difficult-to-treat head and neck cancer

Novel strategies on the way for difficult-to-treat head and neck cancer

Novel strategies are on the way for difficult-to-treat and advanced head and neck cancer, the most heterogeneous group of malignancies which are generally associated with poor survival, and encouraging results have been presented at the first ESMO Asia 2015 Congress in Singapore. [More]
Siemens Healthcare introduces new, cost-effective Biograph Horizon PET/CT system

Siemens Healthcare introduces new, cost-effective Biograph Horizon PET/CT system

Siemens Healthcare has launched the new versatile and cost-effective Biograph Horizon PET/CT system, which offers premium performance at an attractive total cost of ownership. [More]
Anastrozole drug effective in treating early form of breast cancer

Anastrozole drug effective in treating early form of breast cancer

The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial led by Queen Mary University of London. The results of the IBIS-II DCIS trial show that anastrozole is as effective as tamoxifen for this type of breast cancer and could offer a new treatment option for post-menopausal women. [More]
Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or not they received adjuvant chemotherapy, according to data from the phase III DBCG77B clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. [More]
Advertisement
Advertisement